Work

Sparc Analysis in the Phase III MPACT Trial of NAB-Paclitaxel (Nab-P) Plus Gemcitabine (GEM) vs GEM Alone for Patients with Metastatic Pancreatic Cancer (PC)

Year: 2014

Type: article

Source: Annals of Oncology

DOI: 10.1093/annonc/mdu193.4

Authors: M. Hidalgo, C. Plaza, P. Illei, C. Brachmann, C. Heise, D. Pierce, A. Romano, X. Wei, F. López-Ríos, D. Von Hoff

Institutions: Spanish National Cancer Research Centre, Johns Hopkins University, Johns Hopkins Bayview Medical Center, Celgene (United States), Celgene (Switzerland), Translational Genomics Research Institute

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2009102978

FWCI: 4.831

Cites:

Cited by: 31

Related to: 10